Showing results (161-170 of 504) with videos related to

Sort By:
Pageof 51
Diabetologia|August 11, 2019
Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS ProgramZien Zhou, Meg Jardine, Vlado Perkovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2012
The risk of cancer in people with diabetes and chronic kidney diseaseGermaine Wong, Sophia Zoungas, Serigne Lo, et al.
Lancet (London, England)|March 3, 2009
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trialsHiddo J Lambers Heerspink, Toshiharu Ninomiya, Sophia Zoungas, et al.
Diabetes Care|January 22, 2024
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE TrialsSheldon W Tobe, Thomas A Mavrakanas, Harpreet S Bajaj, et al.
The Cochrane Database of Systematic Reviews|May 5, 2015
Interventions for lowering plasma homocysteine levels in kidney transplant recipientsAmy Kang, Sagar U Nigwekar, Vlado Perkovic, et al.
Diabetes, Obesity & Metabolism|August 17, 2021
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysisKent Y Feng, JingWei Li, Juliana Ianus, et al.
Diabetes, Obesity & Metabolism|May 15, 2023
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trialsVikas S Sridhar, Brendon L Neuen, Robert A Fletcher, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 6, 2012
Outcomes of extended-hours hemodialysis performed predominantly at homeMin Jun, Meg J Jardine, Nicholas Gray, et al.
European Journal of Heart Failure|January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trialsSafia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
Pageof 51